These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31030498)

  • 1. Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer.
    Anwar SL; Sari DNI; Kartika AI; Fitria MS; Tanjung DS; Rakhmina D; Wardana T; Astuti I; Haryana SM; Aryandono T
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1223-1228. PubMed ID: 31030498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer.
    Anwar SL; Tanjung DS; Fitria MS; Kartika AI; Sari DNI; Rakhmina D; Wardana T; Astuti I; Haryana SM; Aryandono T
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):491-497. PubMed ID: 32102529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
    Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.
    Peng J; Lin Y; Sheng X; Yuan C; Wang Y; Yin W; Zhou L; Lu J
    BMC Cancer; 2024 Jul; 24(1):789. PubMed ID: 38956544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
    Al-Khanbashi M; Caramuta S; Alajmi AM; Al-Haddabi I; Al-Riyami M; Lui WO; Al-Moundhri MS
    PLoS One; 2016; 11(4):e0152032. PubMed ID: 27064979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
    Yadav P; Mirza M; Nandi K; Jain SK; Kaza RC; Khurana N; Ray PC; Saxena A
    Tumour Biol; 2016 Nov; 37(11):15275-15282. PubMed ID: 27696295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
    Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer.
    Park IH; Kang JH; Lee KS; Nam S; Ro J; Kim JH
    Tumour Biol; 2014 Dec; 35(12):12173-80. PubMed ID: 25179838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
    Müller V; Gade S; Steinbach B; Loibl S; von Minckwitz G; Untch M; Schwedler K; Lübbe K; Schem C; Fasching PA; Mau C; Pantel K; Schwarzenbach H
    Breast Cancer Res Treat; 2014 Aug; 147(1):61-8. PubMed ID: 25086636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
    Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
    Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
    Si H; Sun X; Chen Y; Cao Y; Chen S; Wang H; Hu C
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):223-9. PubMed ID: 23052693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.
    Akkiprik M; Koca S; Uğurlu MÜ; Ekren R; Peker Eyüboğlu İ; Alan Ö; Erzik C; Güllü Amuran G; Telli TA; Güllüoğlu MB; Sezerman U; Yumuk PF
    Clin Breast Cancer; 2020 Aug; 20(4):332-343.e3. PubMed ID: 32201164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.
    Toraih EA; Mohammed EA; Farrag S; Ramsis N; Hosny S
    Mol Diagn Ther; 2015 Jun; 19(3):179-90. PubMed ID: 26063582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
    Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
    Appaiah HN; Goswami CP; Mina LA; Badve S; Sledge GW; Liu Y; Nakshatri H
    Breast Cancer Res; 2011 Sep; 13(5):R86. PubMed ID: 21914171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
    BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.